BVCF
BVCF is a venture capital firm established in 2005, recognized as the first international private equity firm dedicated to investing in China's life sciences sector. Founded by Dr. Zhi Yang, BVCF aims to play a pivotal role in advancing China's life sciences through strategic investments. The firm focuses on a broad range of areas within healthcare, including healthcare services, innovative biologics, in-vitro diagnostics, high-value medical equipment, and medical big data and mobile medicine. With a commitment to leveraging its domain expertise, BVCF invests primarily in China while also engaging in opportunities across the United States, positioning itself as a key player in the evolving landscape of life sciences in China.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Cayman Islands
Stealth BioTherapeutics
Convertible Note in 2018
Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies targeting diseases associated with mitochondrial dysfunction. Founded in 2006 and headquartered in George Town, the Cayman Islands, the company’s lead product candidate, Elamipretide, aims to address both rare genetic and common age-related mitochondrial diseases. Additionally, Stealth BioTherapeutics is developing SBT-20, a small peptide designed to stabilize mitochondrial structure and function under oxidative stress, and SBT-272, which is being evaluated for its potential in treating rare neurodegenerative disorders, including amyotrophic lateral sclerosis. By focusing on mitochondrial health, Stealth BioTherapeutics seeks to improve outcomes for patients suffering from these challenging conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.